| Tag | Content |
|---|
EnhancerAtlas ID | HS170-02225 |
Organism | Homo sapiens |
Tissue/cell | RS4-11 |
Coordinate | chr2:137011800-137013850 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| SPI1 | MA0080.4 | chr2:137013351-137013365 | CACTTCCCCTTTCT | - | 6.22 | | SPIB | MA0081.2 | chr2:137013351-137013363 | CACTTCCCCTTT | - | 6.07 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_09631 | chr2:137010582-137014917 | CD14 | | SE_10274 | chr2:137010741-137014409 | CD19_Primary | | SE_11065 | chr2:137010304-137014964 | CD20 | | SE_61425 | chr2:136945577-137039880 | Toledo | | SE_62403 | chr2:136962507-137014815 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 3 | Chromosome | Start | End |
| chr2 | 137013252 | 137013586 | | chr2 | 137013186 | 137013673 | | chr2 | 137012281 | 137012624 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I136253 | chr2 | 137010941 | 137014177 |
|
Enhancer Sequence | GTCATCTCTG TACTTTTGGT GAACTGGGTT TTTTTCTTCC AAGCTACTCT TCTTGTAGGA 60
GAAAATGGGA AAAGATTTGA CATGCCCTCC ACCTCCCTCC CCCCACTCCA AAATCACCTA 120
CCAGGTAAGG TCTGGAGTTA GTTCAATTTT AGGCTAATCT CTCTGTCTCT TTCTTTTTTT 180
TCTTTGAGAC AGGGTCTCGC TCTGTCACAC AGGCTAGAAC ATAGTGGCAT GACCATAGCT 240
CCATGTAACC TTGAACTCCT GGACTCAAGT CGTCCTCCCA CTTCAGCCTG CTGAGTAGCT 300
GGGACTACAG GCATGCACCA CCATGCTCAG CTAATTTTTA CATTTTTTAG TAGAGACAGG 360
GTGTCATCAC GTTGCTCAGG CTGGTCTCAA ACTCCTGACC TCAAGAGATC CTCCTGCCTT 420
GGCTTCCCAA AGTGCTGAGA TTACAGACAT GAGCTGCTGT GCCTGGCCTC TTTTATCTGA 480
AATATTTTGG AAAGAGAAGA CTCGAGATCT CTGGGACAGG GGAAGAACCT GCAGCTACAG 540
GTTCTTTCTC AGTGTGATCT TAATGAGGTA GGGAGATGGA GTGATGTTGC GGTGACTGTA 600
AGCTTGAATG CTTGATGGTC CTTGTCTTGC CTGTTCTCTG GTTATAGGTT CAGTTTTGTA 660
GATCACTGGT TCTCAAACTT TACTGCATAC AAGGTCCCCT GGGAGCTTTA TACAATGGGG 720
GAAAGTCCCA AGTACACCTT AAACTAATTG AGCCAGAATC TTCAGGAGTG TATCCTTGGC 780
ACCTGCACTT TTTAAAACTC CCCAGGTGAT TCGAAACAAG CCAAGTTTGA GAACCAGTGC 840
TATGCCTTGA AACATCAGGG AGGTGTTCTT AGGGCCTTGT GAAAAAGCAA ACACCAAAGG 900
TTTCATTATG TTAATATAAC TTAAGAACTT AAAAAACTCA AGGGCTTGCT ATTGGCCAAA 960
CACTGTGCCA AATGTTTTCT GTGGATTATC TAATGAAAAC AACAAGTTGA GGTAGGTTAT 1020
TTATTTCATA GAAGAGGAAA CTGACCTTCA AATAAGTTAA GGAACTTGCT CAAGGTGATG 1080
CAGCAGAAAT GTGATTTGAC AGGGCCCTCA CTTCAGAGGC TGCATCTGAC ATTGATGATA 1140
TTTACTACGG TGGAAAATTA CTTTTTCTGT TTGACACACA CGTGCACACA CACACACGTG 1200
TACACACACA CAACTTAGGA ATGTTTGTAA TAATGTATTT CTAAAAAAGA TCTTGCCCAC 1260
CCATTTTTTT TTCAGTAGAT TACCAGAAAT GTGAATTATC AGGGCACTAC AATTCTTGAG 1320
TTTGCTAATT ATTAGCTTTT CACTGAGTAT CATATTGAAG CAAGTGCAGC ATCAGCATCT 1380
CCTGTTTGGA TACAAAGGGT CAGTGATGAG AGCACTCACT AATTTTAAGA GACTTGGAAA 1440
GTTGATGAAA TTTCTGATTT TTAAAGACAG TGTAATGATG TAATGGAAAG GATGGATGAG 1500
ATCAGGTTTT CTTAGTTCTT CCACTTATGA GCTAGATAAT TTTGAGCAAG TCACTTCCCC 1560
TTTCTGGGCT TCAGTTTCCT CATCTGAAAA ATAAGGAAAC CGAATCAAGG GTTTGTTAAA 1620
AGGCCTTTCA CTCTAGATAT GATCCAAAAG ATAAATATTA TCATGGCAGC CTTAGTATAT 1680
CTGACTCTGA AGTCTCAGCA CCTGTTGTCA TTGACCCGTT TATTCGTGCC TGAGTAGCAT 1740
ATTTATAGGA CTGACTTCCT CAAGCTTATG GTTAGTGATG TAACAGGGAA CCAGTCTCCA 1800
TTACACGATG GGCAAATCAC TCAAGTAGCA ACAGACGGTC CAGGAATGAT TGGAAAAGGC 1860
ACACTTTATT TTGTGATGAA AAATTTGTAG GTGGATTTTT AATTTCATAT GGATGAAAGT 1920
GGAAATTCAC AAAGTATATC CAAAGAAAGT CAACCTCGTG GCAGATTTCT GGATCCAGAC 1980
TGGCAGTGTG GGGCCTGTCA CTGCCACAGC GTGGAGAGGC TTGCAGCCAG GTGGAGCTCG 2040
TGGGTGAGGC 2050
|
